Joint Disorders
Also known as: Joint effusion, Temporomandibular, Temporal, Mandible, Joint
Methodology & AI Transparency ⓘ
Joint Disorders Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What are joints? Your joints are places where two or more bones come together.
- 2 Real-world patient consensus: Synonyms for Joint Disorders (M25.40): Joint effusion, Temporomandibular, Temporal (Arthritis & Joints).
- 3 Typical cash cost range: Clinicians assessing Joint Disorders focus on low-grade synovial metalloproteinase in Joint Disorders (M25.40: release) and targeted history.
- 4 Top reported side effects / signs: Key Arthritis & Joints biomarkers for Joint Disorders (M25.40): hs-CRP & Erythrocyte in Joint Disorders (M25.40: Sedimentation Rate) & Weight-Bearing Joint Radiograph [Joint Disorders M25.40] (Preserved joint-space width (M25.40)).
Ask our AI Specialists anything about Joint Disorders
What Is Joint Disorders?
What are joints? Your joints are places where two or more bones come together. Your shoulders, elbows, hips, knees, and knuckles are all joints. Your spine has joints, too. But joints are more than bones. They include the soft tissues around them, such as cartilage, tendons and ligaments. Cartilage is the hard slippery flexible tissue that covers the ends of your bones at a joint. Tendons are tough, flexible bands that connect your muscles to your bones so you can move your joints. Ligaments connect the bones of the joint to each other to keep them stable when you move. What are joint disorders? Joint disorders are diseases or injuries that affect your joints.
Pathophysiology, Underlying Causes & Clinical Presentation
Joint Disorders (M25.40) alters arthritis & joints homeostasis through low-grade synovial metalloproteinase in Joint Disorders (M25.40: release); Cross-referenced with NIH MeSH (Joint Diseases), clinical remission targets Weight-Bearing Joint Radiograph [Joint Disorders M25.40] within Preserved joint-space width (M25.40).
Common Symptoms & Clinical Signs
- • Lupus . This autoimmune disease affects many parts of the body and can cause joint and muscle pain. Some types of lupus often cause arthritis
- • Dislocated joints . A joint is dislocated when the bones are pushed or pulled out of position. A joint dislocation is a medical emergency
- • Presentation of Joint Disorders (M25.40): activity-related deep aching in Joint Disorders (M25.40: joint pain in)
- • Secondary Joint Disorders clinical sign: brief morning joint in Joint Disorders (M25.40: stiffness)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Joint Disorders Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M25.40 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoarthritis, Gout & Joint Pain | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: hs-CRP & Erythrocyte in Joint Disorders (M25.40: Sedimentation Rate) | hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M25.40) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Weight-Bearing Joint Radiograph [Joint Disorders M25.40] | Preserved joint-space width (M25.40) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Uric Acid in Joint Disorders (M25.40: (Gout Target)) | < 6.0 mg/dL (< 5.0 mg/dL with tophi) (M25.40) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Joint Disorders
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Debbies Down and Dirty Deep Tissue Joint and Muscle (Menthol) Debbies Down and Dirty Deep Tissue Joint and Muscle • RxCUI 253020 | Calculi Dissolution Agent | 89% | $0.8804 | $ 71.89 /mo |
| Lidocaine and Camphor Olu Pain Management • RxCUI 2700664 | Amide Local Anesthetic | 85% | $0.0989 | $ 12.50 /mo |
| Lidopro Pain Relief (Capsaicin and Lidocaine) Lidopro Pain Relief • RxCUI 1601095 | Amide Local Anesthetic | 91% | $0.0775 | $ 14.08 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Joint Disorders)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA: What a 642-Participant Study Found In this trial of patients with active PsA who had inadequate response or intolerance to at least one biologic DMARD, upadacitinib 15 mg and 30 mg was more effective than placebo over 24 weeks in improving signs and symptoms of... Annals of the rheumatic diseases • 2021-03-15 • Phase III Randomized Trial | N = 642 | 93/100 | PMID 33272960 ↗ |
| New Insights on Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and: What a 263-Participant Study Found Approximately 45% of. International journal of clinical practice • 2010-07-15 • Randomized Controlled Trial | N = 263 | 93/100 | PMID 20487050 ↗ |
| Managing Psoriatic arthritis: Can Upadacitinib on enthesitis Make a Real Difference? (What a 639-Person Study Found) UPA15 is associated with a comprehensive improvement in enthesitis, with improvements observed after 12 weeks of treatment. Rheumatology (Oxford, England) • 2024-11-01 • Phase III Randomized Trial | N = 639 | 93/100 | PMID 38331400 ↗ |
| New Insights on A Phase 3, 28-week, multicentre, randomised, gold-standard blind, compared: What a 498-Participant Study Found LOR was well tolerated despite not meeting the primary endpoint. Clinical and experimental rheumatology • 2025-05-15 • Phase III Randomized Trial | N = 498 | 93/100 | PMID 39808288 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of ivarmacitinib on swelling and tenderness in small and large joints and Ivarmacitinib 4 mg and 8 mg groups showed greater reductions in bone erosion and synovitis scores under MRI scanning from baseline to W24 versus the placebo group. Naunyn-Schmiedeberg's archives of pharmacology • 2026-05-15 • Phase III Randomized Trial | N = 189 | 88/100 | PMID 41741728 ↗ |
Joint Disorders Patient Community & “People Like Me” Threads
Filter Joint Disorders community threads and patient logs by age, biological sex, dosage, and treatment duration.